Claims for Patent: 6,808,518

Summary for Patent: 6,808,518

Title:	Methods and devices for treating diseased blood vessels
Abstract:	The present invention provides a mechanism by which the physical properties of diseased blood vessel walls can be manipulated to achieve an effective vessel lumen diameter for a prolonged period of time. The methods and devices of the present invention selectively isolate and treat the medial or adventitial layers of these diseased blood vessels. The invention is based on the delivery of proteolytic enzymes and crosslinking agents via specialized delivery devices to a select layer of the diseased blood vessel wall. By isolating and treating these layers of the artery, collagen degrading and collagen crosslinking agents can be delivered so as to affect the diameter of the blood vessels and control blood flow therein.
Inventor(s):	Wellman; Parris S. (Hillsborough, NJ), Weadock; Kevin S. (Princeton, NJ)
Assignee:	Ethicon, Inc. (Somerville, NJ)
Application Number:	09/965,949
Patent Claims:	1. A method for treating a blood vessel having a diseased region along a vessel wall thereof, the treatment comprising the step of manipulating physical properties of the blood vessel wall at the diseased region, wherein the step of manipulating includes: disrupting the integrity of at least one layer of the blood vessel wall to affect vessel wall stiffness at the diseased region by directly delivering to a select layer of the blood vessel wall a quantity of digestive agent sufficient to degrade the collagen of the blood vessel wall at the diseased region so as to achieve a desired vessel diameter. 2. The method of claim 1, wherein the diseased region comprises an atherosclerotic plaque. 3. The method of claim 1, further comprising the step of isolating the diseased region from a remaining portion of the blood vessel prior to treating the blood vessel. 4. The method of claim 2, wherein the step of manipulating occurs either prior to or after an angioplasty procedure to expand the diameter of the blood vessel proximate the atherosclerotic plaque. 5. The method of claim 1, wherein the digestive agent is directly delivered to an adventitial layer of the blood vessel. 6. The method of claim 5, wherein the digestive agent is a proteolytic enzyme. 7. The method of claim 6, wherein the proteolytic enzyme is highly purified mammalian collagenase. 8. The method of claim 1, wherein the treatment involves a drug delivery mechanism selected from the group consisting of a catheter, syringe, film, coating, gel, and sponge. 9. The method of claim 8, wherein the drug delivery mechanism is topically applied to the diseased region of the blood vessel. 10. The method of claim 1, wherein step of manipulating causes an increase in the vessel diameter. 11. The method of claim 10, wherein the step of delivering includes injecting a quantity of the crosslinking agent directly into a medial layer of the blood vessel wall at the diseased region sufficient to promote crosslinking of the collagen at the diseased region. 12. The method of claim 10, wherein the crosslinking agent is selected from the group comprising glutaraldehyde, formaldehyde, carbodiimides, and diisocyanates. 13. A method for treating a blood vessel having a diseased region along a vessel wall thereof, the treatment comprising the step of manipulating physical properties of the blood vessel wall at the diseased region, wherein the step of manipulating includes: disrupting the integrity of at least one layer of the blood vessel wall to affect vessel wall stiffness at the diseased region by directly delivering to a select layer of the blood vessel wall a quantity of digestive agent sufficient to degrade the collagen of the blood vessel wall at the diseased region so as to achieve a desired vessel wall stiffness. 14. A method for treating a blood vessel having a diseased region along a vessel wall thereof, the treatment comprising the step of manipulating physical properties of the blood vessel wall at the diseased region, wherein the step of manipulating includes: modifying the integrity of at least one layer of the blood vessel wall to affect vessel wall stiffness at the diseased region by directly delivering to a select layer of the blood vessel wall a quantity of crosslinking agent sufficient to promote crosslinking of the collagen of the blood vessel wall at the diseased region so as to achieve a desired vessel diameter. 15. The method of claim 14, wherein the diseased region comprises an aneurysm. 16. The method of claim 14, further comprising the step of isolating the diseased region from a remaining portion of the blood vessel prior to treating the blood vessel. 17. The method of claim 14, wherein the treatment involves a drug delivery mechanism selected from the group consisting of a catheter, syringe, film, coating, gel, and sponge. 18. The method of claim 17, wherein the drug delivery mechanism is topically applied to the diseased region of the blood vessel. 19. A method for treating a blood vessel having a diseased region along a vessel wall thereof, the treatment comprising the step of manipulating physical properties of the blood vessel wall at the diseased region, wherein the step of manipulating includes: modifying the integrity of at least one layer of the blood vessel wall to affect vessel wall stiffness at the diseased region by directly delivering to a select layer of the blood vessel wall a quantity of crosslinking agent sufficient to promote crosslinking of the collagen of the blood vessel wall at the diseased region so as to achieve a desired vessel wall stiffness.

Details for Patent 6,808,518

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2039-03-29